Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus.
Sina NabiyiFirozeh SajediAlireza ZamaniMahdi Behzad
Published in: Human immunology (2024)
Sitagliptin administration has a regulatory effect on the aggressive expression of IL-29 and its signaling molecules including FOS, NF-AT2 and NF-KB1 in T2D.